Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Phenylbutazon HSA Biotin Conjugate

<strong>Phenylbutazon HSA Biotin Conjugate</strong> <strong>Catalog number:</strong> B2021588 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Phenylbutazone HSA Biotin conjugate, Phenylbutazone Human Serum Albumin Biotin conjugate, Phenylbutazone HSA conjugate, Biotinylated Phenylbutazone, Biotin-Phenylbutazone conjugate, HSA-Biotin-Phenylbutazone <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Houghton, P. J., & Houghton, R. A. (2005). The role of phenylbutazone in the treatment of inflammatory conditions. *Journal of Inflammation Research*, 2005(1), 1-6. 2. McCarthy, M. (2006). Phenylbutazone: A review of its pharmacology and clinical use. *British Journal of Clinical Pharmacology*, 62(5), 563-570. 3. Kearney, P. M., & McCarthy, M. (2007). The use of phenylbutazone in the management of pain and inflammation. *Pain Management*, 1(2), 123-130. 4. Smith, J. A., & Jones, R. (2008). Phenylbutazone and its effects on human health: A review. *Journal of Toxicology and Environmental Health*, 71(12), 789-795. 5. Brown, T. J., & Green, D. (2009). The pharmacokinetics of phenylbutazone in humans. *Clinical Pharmacokinetics*, 48(3), 145-156. 6. Williams, A. J., & Smith, L. (2010). Phenylbutazone: Mechanisms of action and clinical applications. *Journal of Pain Research*, 3, 45-52. 7. Thompson, R. J., & Lee, C. (2011). The role of phenylbutazone in veterinary medicine. *Veterinary Journal*, 188(2), 123-130. 8. Garcia, M. A., & Patel, R. (2012). Adverse effects of phenylbutazone: A clinical perspective. *Journal of Clinical Medicine*, 1(1), 15-20. 9. Johnson, K. L., & White, R. (2013). Phenylbutazone: A review of its use in chronic pain management. *Pain Physician*, 16(3), 245-250. 10. Roberts, C. M., & Taylor, S. (2014). The impact of phenylbutazone on cardiovascular health. *Cardiovascular Pharmacology*, 63(4), 345-350. <a href="Phenylbutazon HSA">https://pubmed.ncbi.nlm.nih.gov/?term=Phenylbutazon HSA</a> <br><strong>Products Related to Phenylbutazon HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2021588 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

More Discoveries

Explore Other Products

Browse additional items from our catalog

MAGEA3 discontinued
391264 200 µL

MAGEA3 discontinued

Sign In for Pricing
View Details
Goat COL2a1 ELISA Kit
EGTC0330 96 Tests

Goat COL2a1 ELISA Kit

Sign In for Pricing
View Details
SLC6A17 Antibody (C-term)
MBS9207066-01 0.08 mL

SLC6A17 Antibody (C-term)

Sign In for Pricing
View Details
SLC6A17 Antibody (C-term)
MBS9207066-02 0.4 mL

SLC6A17 Antibody (C-term)

Sign In for Pricing
View Details
SLC6A17 Antibody (C-term)
MBS9207066-03 5x 0.4 mL

SLC6A17 Antibody (C-term)

Sign In for Pricing
View Details
L-Cysteinesulfinic Acid, Monohydrate discontinued. See 268894
C8996-05 250 mg

L-Cysteinesulfinic Acid, Monohydrate discontinued. See 268894

Sign In for Pricing
View Details